Pharmacological Overview of the Drug Candidate BGP-15

Ágota Pető; Dóra Kósa; Pálma Fehér; Zoltán jhelyi; Dávid Sinka; Miklós Vecsernyés; Zoltán Szilvássy; Béla Juhász; Zoltán Csanádi; Ildikó Bácskay

doi:10.33892/aph.2021.91.298-299

Pharmacological Overview of the Drug Candidate BGP-15

Authors

Ágota Pető University of Debrecen, Faculty of Pharmacy, Department of Pharmaceutical Technology, H-4032, Debrecen Hungary
Dóra Kósa University of Debrecen, Faculty of Pharmacy, Department of Pharmaceutical Technology, H-4032, Debrecen Hungary
Pálma Fehér University of Debrecen, Faculty of Pharmacy, Department of Pharmaceutical Technology, H-4032, Debrecen Hungary
Zoltán jhelyi University of Debrecen, Faculty of Pharmacy, Department of Pharmaceutical Technology, H-4032, Debrecen Hungary
Dávid Sinka University of Debrecen, Faculty of Pharmacy, Department of Pharmaceutical Technology, H-4032, Debrecen Hungary
Miklós Vecsernyés University of Debrecen, Faculty of Pharmacy, Department of Pharmaceutical Technology, H-4032, Debrecen Hungary
Zoltán Szilvássy University of Debrecen, Faculty of Medicine, Department of Pharmacology and Pharmacotherapy, H-4032, Debrecen, Hungary
Béla Juhász University of Debrecen, Faculty of Medicine, Department of Pharmacology and Pharmacotherapy, H-4032, Debrecen, Hungary
Zoltán Csanádi University of Debrecen, Faculty of Medicine, Institute of Cardiology, H-4032, Debrecen, Hungary
Ildikó Bácskay University of Debrecen, Faculty of Pharmacy, Department of Pharmaceutical Technology, H-4032, Debrecen Hungary

DOI:

https://doi.org/10.33892/aph.2021.91.298-299

Keywords:

BGP-15, chaperone co-inducer, PARP inhibitor, insulin sensitizer

PDF for Pető et al. APH 2021;91:298-299

Published

2021-11-15

How to Cite

(1)

Pető, Ágota; Kósa, D.; Fehér, P.; jhelyi, Z.; Sinka, D.; Vecsernyés, M.; Szilvássy, Z.; Juhász, B.; Csanádi, Z.; Bácskay, I. Pharmacological Overview of the Drug Candidate BGP-15. Acta Pharm Hung 2021, 91, 298-299.